Prevention of heart failure progression: current approaches

被引:0
|
作者
Lechat, P [1 ]
机构
[1] Pitie Salpetriere Hosp, Dept Pharmacol, F-7513 Paris, France
关键词
heart failure; compensatory mechanisms; sympathetic nervous system; renin-angiotensin-aldosterone system; diuretics; ACE inhibitors; alpha- and beta-adrenergic blockers;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure results from damage and stress to the myocardium whatever the aetiology. An increase in stress by cardiac overload is initially overcome by compensatory mechanisms that maintain blood pressure through a combination of the sympathetic nervous system and the renin-angiotensin-aldosterone system. These mechanisms may also alter myocyte function and induce progressive cell death and replacement by fibrous tissue. Disease therapy must reduce cardiac loading and avoid blood pressure control by mechanisms that have deleterious effects. Therapy includes diuretics, vasodilators and alpha-and beta-adrenergic blockade. Complete blockade of all receptors involved in the adverse effects of neurohormonal stimulation might represent an ultimate therapy objective, and improve subsequent prognosis. Large clinical trials are in progress to determine the therapy of choice in the prevention of progression of heart failure.
引用
收藏
页码:B12 / B18
页数:7
相关论文
共 50 条
  • [31] Slowing the progression of heart failure
    Cohn, JN
    EUROPEAN HEART JOURNAL, 1996, 17 (11) : 1609 - 1611
  • [32] Diuretic therapy in heart failure: current controversies and new approaches for fluid removal
    Brandimarte, Filippo
    Mureddu, Gian Francesco
    Boccanelli, Alessandro
    Cacciatore, Giuseppe
    Brandimarte, Camillo
    Fedele, Francesco
    Gheorghiade, Mihai
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2010, 11 (08) : 563 - 570
  • [33] Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches
    Aimo, Alberto
    Borrelli, Chiara
    Vergaro, Giuseppe
    Piepoli, Massimo F.
    De Caterina, Alberto R.
    Mirizzi, Gianluca
    Valleggi, Alessandro
    Raglianti, Valentina
    Passino, Claudio
    Emdin, Michele
    Giannoni, Alberto
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) : 4807 - 4822
  • [34] Surgical Approaches in Heart Failure
    Falls, Candice
    Kolodziej, Andrew R.
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2019, 31 (03) : 267 - +
  • [35] Naturopathic approaches in heart failure
    Dobos G.J.
    MMW - Fortschritte der Medizin, 2018, 160 (8) : 22 - 24
  • [36] Prevention of heart failure with telemedicine
    Vasoncelos, G.
    Camargo, M. E. J.
    Oliveira, L. R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S257 - S257
  • [37] Secondary prevention of heart failure
    Maranhao, Mario F. De Camargo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 11 - 12
  • [38] Prevention of worsening heart failure
    Malbos, Damien
    Buxeraud, Jacques
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2021, 60 (608): : 19 - 22
  • [39] Primary Prevention for Heart Failure
    Hozawa, Atsushi
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S136 - S136
  • [40] Secondary Prevention in Heart Failure
    Robinson, Melissa R.
    Epstein, Andrew E.
    Callans, David J.
    HEART FAILURE CLINICS, 2011, 7 (02) : 185 - +